Biggest News Aggregation in the World
๐Ÿ“ฐ Instil Bio News

Page 2 - Instil Bio News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Instil Bio. Real-time updates on events, politics, business and more.

Neurona Therapeutics Appoints James Stutz as Chief Financial Officer and Chief Business Officer

SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced the appointment of James Stutz, a business and finance executive with over 20 years of experience in the biopharma industry, as chief financial officer (CFO) and chief business officer (CBO). “We are delighted to welcome James to the Neurona team and look forward to the va...
United States James Stutz Coryr Nicholas Alios Biopharma Elizabeth Wolffe Sylvia Wheeler
Source: yahoo.com

Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023 - Mister Car Wash (NYSE:MCW), Inter & Co (NASDAQ:INTR), Roku (NASDAQ:ROKU), Citizens Financial Group (NYSE:CFG), Clarus (NASDAQ:CLAR), CNO Finl Group (NYSE:CNO), OPKO Health (NASDAQ:OPK), Pfizer (NYSE:PFE), Banco Latinoamericano (NYSE:BLX), Schneider National (NYSE:SNDR), ContextLogic (NASDAQ:WISH), Burlington Stores (NYSE:BURL), Pentair (NYSE:PNR), Unity Software (NYSE:U), Ashland (NYSE:ASH), Fox Factory Hldg (NASDAQ:FOXF), Academy Sports (NASDAQ:ASO), Badger Meter (NYSE:BMI), Hibbett (NASDAQ:HIBB), FREYR Battery (NYSE:FREY), TJX Companies (NYSE:TJX), Wingstop (NASDAQ:WING), Symbotic (NASDAQ:SYM), C3.ai (NYSE:AI), Micron Technology (NASDAQ:MU), Arlo Technologies (NYSE:ARLO), Xylem (NYSE:XYL), Corebridge Financial (NYSE:CRBG), Walt Disney (NYSE:DIS), Warner Music Gr (NASDAQ:WMG), Paramount Resources (OTC:PRMRF), Quest Diagnostics (NYSE:DGX), Gold Royalty (AMEX:GROY), RH (NYSE:RH), Instil Bio (NASDAQ:TIL), Zurn Elkay Water (NYSE:ZWS), RealReal (NASDAQ:REAL), Ross Stores (NASDAQ:ROST), Generac Hldgs (NYSE:GNRC), NET Power (NYSE:NPWR), Freeport-McMoRan (NYSE:FCX), Atlassian (NASDAQ:TEAM), Establishment Labs Hldgs (NASDAQ:ESTA), Intercept Pharma (NASDAQ:ICPT), Tenaris (NYSE:TS)

Hibbett Inc Atlassian Corp Raymond James Piper Sandler Bio Inc Roku Inc

Biomarkers predict benefit of adjuvant nivolumab in resected melanoma

CHICAGO — Several biomarkers predicted outcomes with adjuvant nivolumab vs. placebo for patients with resected stage IIB or IIC melanoma, according to study results presented at ASCO Annual Meeting.In contrast to prior findings in melanoma, no biomarkers appeared prognostic for RFS among patients who received placebo.
United States Western Australia Bymark Leiser Castle Biosciences Brian Gastman Bristol Myers Squibb
Source: healio.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Pembrolizumab Yields High Response Rates for Patients With Unresectable Metastatic Desmoplastic Melanoma

Patients with unresectable metastatic desmoplastic melanoma achieved high response rates when treated with single-agent pembrolizumab in the SWOG S1512 trial, according to data presented during the 2023 AACR Annual Meeting.
United States Castle Biosciences Arthurg James Kari Kendra Iovance Biotherapeutics Department Of Oncologic Sciences

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science